TL1A [Biotinylated] : DR3 Inhibitor Screening ELISA Kit

ユーザーレビュー
製品番号/仕様
価格
数量
EP-168-96tests
$770.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Materials Provided

    ID
    Components
    Size
    EP168-C01
    High-bind Plate
    1 plate
    EP168-C02
    Human DR3
    100 μg
    EP168-C03
    Human TL1A-SABC
    5 μg
    EP168-C04
    Human Anti-TL1A Neutralizing Antibody
    100 μg
    EP168-C05
    Coating Buffer
    12 mL
    EP168-C06
    20xWashing Buffer
    50 mL
    EP168-C07
    Blocking Buffer
    50 mL
    EP168-C08
    Substrate Solution
    12 mL
    EP168-C09
    Stop Solution
    7 mL

  • Product Overview

    TL1A [Biotinylated] : DR3 Inhibitor Screening ELISA Kit is based on a competition-ELISA method, is used to screening for inhibitors of human TL1A binding to human DR3. The kit is designed to provide a reliable solution for the screening of antibodies and small molecule inhibitors in the early stages, as well as QC release, to help researchers quickly screen and validate drugs, effectively improving research and development efficiency. It can also be used as a universal detection tool to identify the ability of human TL1A binding to human DR3.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Typical Data 

    Please refer to DS document for the assay protocol.

     TL1A-DR3 TYPICAL DATA

    Serial dilutions of Human Anti-TL1A Neutralizing antibody (Catalog # EP168-C04) (1:1 serial dilution, from 5 μg/mL to0.0390625 μg/mL) was added into Human DR3 : Biotinylated Human TL1A binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).
    For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The example data is for reference only.

ユーザーレビュー
コメントを投稿

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8